Temperate enterococcal bacteriophages: genetic features and practical application-Reference-Cited by-同舟云学术

Temperate enterococcal bacteriophages: genetic features and practical application

Published:2022 Issue:3 Volume:24 Page:213-218
ISSN:2686-9586
Container-title:Clinical Microbiology and Antimicrobial Chemotherapy
language:ru
Short-container-title:CMAC

Author:

Tkachev Pavel V.¹,Goncharov A.E.¹,Dmitriev A.V.¹

Affiliation:

1. Institute of Experimental Medicine (Saint-Petersburg, Russia)

Abstract

Temperate bacteriophages are of interest as carriers and vectors of pathogenicity factors that determine an epidemic potential of opportunistic bacteria as well as biotechnology objects. This review describes studies of temperate bacteriophages infecting bacteria of the genus Enterococcus, including strains associated with the development of nosocomial infections. Genetic features of moderate enterococcal phages as well as their potential for practical application in medicine are considered.

Publisher

Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),Epidemiology

Reference54 articles.

1. Salmond G.P., Fineran P.C. A century of the phage: past, present and future. Nat Rev Microbiol. 2015;13(12):777786. DOI: 10.1038/nrmicro3564

2. Letarov A.V. Sovremennye konczepczii biologii bakteriofagov. M.: DeLi, 2020. 383 p. Russian.

3. Gordillo Altamirano F.L., Barr J.J. Phage therapy in the postantibiotic era. Clin Microbiol Rev. 2019;32(2):e0006618. DOI: 10.1128/CMR.00066-18

4. Monteiro R., Pires D.P., Costa A.R., Azeredo J. Phage therapy: going temperate? Trends Microbiol. 2019;27(4):368-378. DOI: 10.1016/j.tim.2018.10.008

5. Dublanchet A., Fruciano E. A short history of phage therapy. Med Mal Infect. 2008;38(8):415-420. DOI: 10.1016/j.medmal.2008.06.016